Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Effectiveness of the Extended Longevity Protocol on the Epigenetic Aging Rate in Healthy Individuals

NCT05296993 is registered in ClinicalTrials.gov with TruDiagnostic as lead sponsor.

NCT NCT05296993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05296993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Effectiveness of the Extended Longevity Protocol on the Epigenetic Aging Rate in Healthy Individuals
Lead sponsor
TruDiagnostic
Phase
Phase 2
Overall status
Unknown status
Start date
May 25, 2021
Completion date
December 31, 2023
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging